Drug maker Merck & Co. Inc. has won a Chancery Court case to keep rival SmithKline Beecham Pharmaceuticals Co. from selling a chicken pox vaccine in the United States and Canada for three years.
It’s just hard to know why.
Drug maker Merck & Co. Inc. has won a case to keep rival SmithKline Beecham Pharmaceuticals Co. from selling a chicken pox vaccine in the United States and Canada for three years. It's just hard to know why. Trade secrets were at stake, so the opinion filed Aug. 5 was sealed. Merck went to court almost three years ago to complain that SmithKline, located in Philadelphia, had misappropriated and misused trade secrets, thereby damaging its marketing prospects for the vaccine sold under the name Varivax.
August 24, 1999 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Drug maker Merck & Co. Inc. has won a Chancery Court case to keep rival SmithKline Beecham Pharmaceuticals Co. from selling a chicken pox vaccine in the United States and Canada for three years.
It’s just hard to know why.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS